HopeStage
Back to all studies
CompletedNCT06593093

Combined support to reduce overdose risk after opioid treatment

About this titleRead the official source — NCT06593093
Medication studyAges 19+United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 19 years.

Listed locations
BirminghamSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: February 13, 2025
Recruitment status
Completed
Enrollment listed in the registry
30
Sponsor
University of Alabama at Birmingham
Sponsor type
University
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
Over 19 Years
Official registry ID
NCT06593093
Official title
Show the full official title

A Bundled Intervention to End Opioid Overdose by Increasing Treatment Uptake Post Emergency Department Discharge

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Birmingham

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Alabama at Birmingham, a university.

Who was this study for?

Listed age limits: from 19 years.

Want to explore more studies?

Explore studies